High expression of the non-receptor tyrosine kinase FER is an independent prognostic factor that correlates with poor survival in breast cancer patients. To investigate whether the kinase activity is essential for FER oncogenic properties, we developed an ATP analogue-sensitive knock-in allele (FERASKI). Specific FER kinase inhibition in MDA-MB-231 cells reduces migration, invasion, and metastasis in a mouse model of breast cancer. Using the FERASKI system, we identify SKI family transcriptional corepressor 1 (SKOR1) as a direct FER kinase substrate. SKOR1 loss phenocopies FER inhibition, leading to impaired proliferation, migration and invasion, and inhibition of breast cancer growth and metastasis formation in mice. We show that the candidate FER phosphorylation residue, SKOR1-Y234, is essential for FER-dependent tumor progression features. Finally, our work suggests that the SKOR1-Y234 residue promotes Smad2/3 signaling through SKOR1 binding to Smad3 attenuation. Our study thus identifies SKOR1 as a mediator of FER-dependent progression of high-risk breast cancers.
SKOR1 mediates FER kinase-dependent invasive growth of breast cancer cells
- Award Group:
- Funder(s): KWF Kankerbestrijding
- Award Id(s): UU2014-7201
- Funder(s):
- Award Group:
- Funder(s): HORIZON EUROPE European Innovation Council
- Award Id(s): 731957
- Funder(s):
- Award Group:
- Funder(s): Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- Award Id(s): NWO-TOP 02007
- Funder(s):
- Views Icon Views
-
Article Versions Icon
Versions
- Accepted Manuscript 09 January 2023
- Share Icon Share
-
Tools Icon
Tools
- Search Site
Lilian M. Sluimer, Esme Bullock, Max A. K. Rätze, Lotte Enserink, Celine Overbeeke, Marten Hornsveld, Valerie G. Brunton, Patrick W. B. Derksen, Sandra Tavares; SKOR1 mediates FER kinase-dependent invasive growth of breast cancer cells. J Cell Sci 2023; jcs.260243. doi: https://doi.org/10.1242/jcs.260243
Download citation file:
Sign in
Client Account
Sign in via your institution
Sign in via ShibbolethAdvertisement
Cited by
JCS Journal Meeting 2023: Imaging Cell Dynamics

Our 2023 Journal Meeting on ‘Imaging Cell Dynamics’ will be held from 14-17 May 2023 in Lisbon, Portugal. We have a limited number of spaces left so sign up now! Registration deadline: 31 March.
Call for papers: Cell and Tissue Polarity
-PolarityCFP.png?versionId=4491)
We are welcoming submissions for our next special issue, which will focus on ‘Cell and tissue polarity’ and will be guest edited by David Bryant. Submission deadline: 15 July.
Webinar: Increasing the visibility and impact of your research
-HUBSwebinar.jpg?versionId=4491)
Would you like to increase the visibility and impact of your research and raise your profile internationally? If so, register for the very practical webinar we are running in association with HUBS on 23 February 2023.
Cell scientist to watch: Gautam Dey

We interviewed Gautam Dey, who became a group leader at EMBL in Heidelberg, Germany, in 2021. His lab investigates the fundamental organisational principles and evolutionary dynamics of the nuclear compartment across eukaryotes.
Mechanisms of eukaryotic transcription termination at a glance

Check out our latest Cell Science at a Glance article and accompanying poster for an overview of the current understanding about the mechanisms of transcription termination by the three eukaryotic RNAPs.